Amarin Corp Plc (AMRN)

[fsulevine]

IMHO, the only numbers that matter are not the EPS... they are script growth and revenue. Big losses won’t matter to a potential buyout or to an investor looking for such. What will matter are the increasing number of people using the product. The court case outcome will put a definite time when generics can come to market, and with potential competition having failed their trials, that is one less thing to worry about. After the trial is over, unless Amarin loses, the only thing that would hold back the share price would be market manipulators or bad script/revenue numbers.